Clinicopathological relevance of UbcH10 in breast cancer

Takeo Fujita, Hirokuni Ikeda, Kensuke Kawasaki, Naruto Taira, Yutaka Ogasawara, Akira Nakagawara, Hiroyoshi Doihara

Research output: Contribution to journalArticle

21 Citations (Scopus)

Abstract

Abrogated mitotic progression is a common hallmark of cancer. UbcH10, one of the components of the ubiquitin/proteasome pathway, plays a pivotal role in the regulation of mitotic progression. Abnormal UbcH10 activity is reported in certain types of human cancers; its overexpression is occasionally encountered in cancerous tissue compared with adjacent normal tissue. Current studies have suggested the critical role of UbcH10 in the spindle assembly checkpoint and the subsequent accurate separation of sister chromatids, which is orchestrated by a series of molecular interactions governed by the complex and diverse cell cycle machinery. To validate the potential role of UbcH10 in cell proliferation in cancer, we have analyzed the clinicopathological relevance of UbcH10 in progression of breast cancer using a combinatorial approach of human tumor arrays and biochemical analyses. Our results show that the percentage of tested samples which stained positive for UbcH10 in breast cancer tissues is significantly higher compared to the adjacent nonmalignant tissue. Furthermore, results from the clinicopathological analysis have revealed that elevated expression of UbcH10 is associated with higher histological grade tumors. In addition, depletion of UbcH10 by RNA interference in breast cancer cells resulted in decreased cellular proliferation, while overexpression of UbcH10 significantly enhanced cellular growth in breast cancer. Our results suggest a pathological correlation between UbcH10 and cell proliferation in breast cancer. Thus, aberrant UbcH10 activity may induce the dysfunction of proper cell cycle progression and result in the aggressive behavior of tumor cells in patients with breast cancer.

Original languageEnglish
Pages (from-to)238-248
Number of pages11
JournalCancer Science
Volume100
Issue number2
DOIs
Publication statusPublished - 2009

Fingerprint

Breast Neoplasms
Neoplasms
Cell Proliferation
Cell Cycle
M Phase Cell Cycle Checkpoints
Chromatids
Proteasome Endopeptidase Complex
Ubiquitin
RNA Interference
Siblings
Growth

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Clinicopathological relevance of UbcH10 in breast cancer. / Fujita, Takeo; Ikeda, Hirokuni; Kawasaki, Kensuke; Taira, Naruto; Ogasawara, Yutaka; Nakagawara, Akira; Doihara, Hiroyoshi.

In: Cancer Science, Vol. 100, No. 2, 2009, p. 238-248.

Research output: Contribution to journalArticle

Fujita, Takeo ; Ikeda, Hirokuni ; Kawasaki, Kensuke ; Taira, Naruto ; Ogasawara, Yutaka ; Nakagawara, Akira ; Doihara, Hiroyoshi. / Clinicopathological relevance of UbcH10 in breast cancer. In: Cancer Science. 2009 ; Vol. 100, No. 2. pp. 238-248.
@article{84f01264ad4d4d648343abf676b5e119,
title = "Clinicopathological relevance of UbcH10 in breast cancer",
abstract = "Abrogated mitotic progression is a common hallmark of cancer. UbcH10, one of the components of the ubiquitin/proteasome pathway, plays a pivotal role in the regulation of mitotic progression. Abnormal UbcH10 activity is reported in certain types of human cancers; its overexpression is occasionally encountered in cancerous tissue compared with adjacent normal tissue. Current studies have suggested the critical role of UbcH10 in the spindle assembly checkpoint and the subsequent accurate separation of sister chromatids, which is orchestrated by a series of molecular interactions governed by the complex and diverse cell cycle machinery. To validate the potential role of UbcH10 in cell proliferation in cancer, we have analyzed the clinicopathological relevance of UbcH10 in progression of breast cancer using a combinatorial approach of human tumor arrays and biochemical analyses. Our results show that the percentage of tested samples which stained positive for UbcH10 in breast cancer tissues is significantly higher compared to the adjacent nonmalignant tissue. Furthermore, results from the clinicopathological analysis have revealed that elevated expression of UbcH10 is associated with higher histological grade tumors. In addition, depletion of UbcH10 by RNA interference in breast cancer cells resulted in decreased cellular proliferation, while overexpression of UbcH10 significantly enhanced cellular growth in breast cancer. Our results suggest a pathological correlation between UbcH10 and cell proliferation in breast cancer. Thus, aberrant UbcH10 activity may induce the dysfunction of proper cell cycle progression and result in the aggressive behavior of tumor cells in patients with breast cancer.",
author = "Takeo Fujita and Hirokuni Ikeda and Kensuke Kawasaki and Naruto Taira and Yutaka Ogasawara and Akira Nakagawara and Hiroyoshi Doihara",
year = "2009",
doi = "10.1111/j.1349-7006.2008.01026.x",
language = "English",
volume = "100",
pages = "238--248",
journal = "Cancer Science",
issn = "1347-9032",
publisher = "Wiley-Blackwell",
number = "2",

}

TY - JOUR

T1 - Clinicopathological relevance of UbcH10 in breast cancer

AU - Fujita, Takeo

AU - Ikeda, Hirokuni

AU - Kawasaki, Kensuke

AU - Taira, Naruto

AU - Ogasawara, Yutaka

AU - Nakagawara, Akira

AU - Doihara, Hiroyoshi

PY - 2009

Y1 - 2009

N2 - Abrogated mitotic progression is a common hallmark of cancer. UbcH10, one of the components of the ubiquitin/proteasome pathway, plays a pivotal role in the regulation of mitotic progression. Abnormal UbcH10 activity is reported in certain types of human cancers; its overexpression is occasionally encountered in cancerous tissue compared with adjacent normal tissue. Current studies have suggested the critical role of UbcH10 in the spindle assembly checkpoint and the subsequent accurate separation of sister chromatids, which is orchestrated by a series of molecular interactions governed by the complex and diverse cell cycle machinery. To validate the potential role of UbcH10 in cell proliferation in cancer, we have analyzed the clinicopathological relevance of UbcH10 in progression of breast cancer using a combinatorial approach of human tumor arrays and biochemical analyses. Our results show that the percentage of tested samples which stained positive for UbcH10 in breast cancer tissues is significantly higher compared to the adjacent nonmalignant tissue. Furthermore, results from the clinicopathological analysis have revealed that elevated expression of UbcH10 is associated with higher histological grade tumors. In addition, depletion of UbcH10 by RNA interference in breast cancer cells resulted in decreased cellular proliferation, while overexpression of UbcH10 significantly enhanced cellular growth in breast cancer. Our results suggest a pathological correlation between UbcH10 and cell proliferation in breast cancer. Thus, aberrant UbcH10 activity may induce the dysfunction of proper cell cycle progression and result in the aggressive behavior of tumor cells in patients with breast cancer.

AB - Abrogated mitotic progression is a common hallmark of cancer. UbcH10, one of the components of the ubiquitin/proteasome pathway, plays a pivotal role in the regulation of mitotic progression. Abnormal UbcH10 activity is reported in certain types of human cancers; its overexpression is occasionally encountered in cancerous tissue compared with adjacent normal tissue. Current studies have suggested the critical role of UbcH10 in the spindle assembly checkpoint and the subsequent accurate separation of sister chromatids, which is orchestrated by a series of molecular interactions governed by the complex and diverse cell cycle machinery. To validate the potential role of UbcH10 in cell proliferation in cancer, we have analyzed the clinicopathological relevance of UbcH10 in progression of breast cancer using a combinatorial approach of human tumor arrays and biochemical analyses. Our results show that the percentage of tested samples which stained positive for UbcH10 in breast cancer tissues is significantly higher compared to the adjacent nonmalignant tissue. Furthermore, results from the clinicopathological analysis have revealed that elevated expression of UbcH10 is associated with higher histological grade tumors. In addition, depletion of UbcH10 by RNA interference in breast cancer cells resulted in decreased cellular proliferation, while overexpression of UbcH10 significantly enhanced cellular growth in breast cancer. Our results suggest a pathological correlation between UbcH10 and cell proliferation in breast cancer. Thus, aberrant UbcH10 activity may induce the dysfunction of proper cell cycle progression and result in the aggressive behavior of tumor cells in patients with breast cancer.

UR - http://www.scopus.com/inward/record.url?scp=58549096318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58549096318&partnerID=8YFLogxK

U2 - 10.1111/j.1349-7006.2008.01026.x

DO - 10.1111/j.1349-7006.2008.01026.x

M3 - Article

C2 - 19038004

AN - SCOPUS:58549096318

VL - 100

SP - 238

EP - 248

JO - Cancer Science

JF - Cancer Science

SN - 1347-9032

IS - 2

ER -